Boeing Gains 737-7 Approval as Investors Question Stock Price

Boeing has received an important regulatory boost after the U.S. Federal Aviation Administration cleared its 737-7 for commercial service. The boeing ah-64 apache is also part of Boeing’s broader aviation and defense portfolio, while investors are weighing whether Boeing stock has risen too far following its recent recovery.

737-7 Approval Strengthens Boeing’s Outlook

The FAA granted Boeing an amended type certificate for the 737-7 on August 3, clearing the aircraft for commercial operations. The smallest and longest-range member of the 737 MAX family is designed to carry between 135 and 160 passengers in a two-class configuration and offers additional range compared with other MAX variants.

The certification is significant because the 737-7 program faced years of delays as Boeing and regulators worked through safety and technical requirements. The approval allows Boeing to move closer to delivering aircraft to customers and potentially generating additional cash from planes that have been waiting for certification.

New Technology Deal Adds to the Story

Boeing has also agreed to test technology from Odysight.ai, a company developing predictive maintenance solutions. The partnership gives Boeing another opportunity to use technology aimed at monitoring aircraft systems and identifying potential maintenance issues before they become more serious.

Together, the 737-7 approval and technology agreement have strengthened the narrative around Boeing’s recovery. The company’s shares have shown positive short-term momentum, with Simply Wall St reporting an 8.24% return over 30 days and a 5.01% return over 90 days as of its August 16 analysis.

Valuation Remains a Concern

Despite the positive developments, some investors remain cautious about Boeing’s valuation. Simply Wall St’s most-followed valuation narrative estimated fair value at about $160.01 per share, compared with a recent closing price of $231.67. That would put the stock substantially above the site’s estimated value.

The valuation argument depends heavily on Boeing achieving stronger revenue growth, improving margins and maintaining a premium valuation multiple. Simply Wall St noted that justifying a price around $230 would require assumptions including roughly 9.3% revenue growth and a 10% net margin.

For Boeing, the 737-7 approval is an important step forward, but investors still face questions about execution, profitability, debt and future cash flow. The company must turn regulatory progress and new technology initiatives into sustained financial improvement. That could determine whether the recent rise in Boeing shares represents the beginning of a longer recovery or a valuation that has already priced in much of the expected progress.

Source : simplywall.st